Navigation Links
Unilever Extends Their GeneGo MetaCore License
Date:7/8/2008

ST. JOSEPH, Mich., July 8 /PRNewswire/ -- GeneGo, Inc., the leading systems biology tools company, announced today that Unilever extended its license to GeneGo products. Unilever uses systems analysis tools for research in its consumer goods and skin care product development.

"Unilever was one of GeneGo's first customers in Europe, and we are very pleased to continue working with them," said Julie Bryant, GeneGo's VP of Business development. "Unilever is a consumer goods company that develops foods and home and personal care products. Unilever's Safety & Environmental Assurance Centre provides independent safety assurance and support for Unilever products, making safety decisions independently of commercial considerations. Metacore helps it's scientists in understanding the mechanisms underlying safety endpoints, as part of its ongoing effort to develop novel ways of ensuring consumer safety. "Our database is rich in natural products and components used in consumer and food products, and we have an expanded ontology for skin diseases and processes to help Unilever researchers."

About GeneGo, Inc.

GeneGo, Inc. develops systems biology technology for life science research. The original computational MetaDiscovery(TM) platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, microRNA assays and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo's flagship product, MetaCore 4.7(TM), assists pharmaceutical scientists in the areas of target selection and validation, identification of biomarkers for disease states and toxicology. The second product, MetaDrug 4.7(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore. For more information, please visit the company's web site at http://www.genego.com

MetaCore(TM), MetaBase(TM), MetaDrug(TM), MetaLink(TM), MetaDiscovery(TM), MetaTox(TM), MetaMiner(TM) and 1-2-3 Workflow(TM) are trademarks of GeneGo, Inc.


'/>"/>
SOURCE GeneGo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Rentschler Biotechnologie Extends Capacities for Mammalian Cell Culture Manufacturing
2. Symmetry Medical Extends 10-K Filing Beyond April 14, 2008 Target
3. Gerson Lehrman Group Extends Partnership With BIO to Provide Scientific Expertise for the First Annual BIO National Venture Conference
4. Ingenuity Systems Extends Enterprise-Level Software Agreement With GlaxoSmithKline
5. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
6. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
7. Netsmart Technologies Extends Relationship with Manatee Glens for Enterprise Behavioral Health Software Solutions
8. GSK Extends GeneGo License and Adds New Products
9. Roche Extends Tender Offer for Ventana
10. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
11. Organon Extends MetaCore License and Adds MetaLink
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... -- This report analyzes the worldwide markets for Biofuel Enzymes ... Cellulase, and Others. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Read the full report: ... for the period 2015 through 2022. Also, a six-year historic ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... with catheters associated with peritoneal dialysis, announced today that it has published the ... connection system in Peritoneal Dialysis International (PDI), the official Journal of the ...
(Date:2/18/2017)... Kurzlehrgang mit Fokus auf Assay zum ... metaproteomische Analyse des Darm-Mikrobioms bei Säuglingen dar   ... Wie ... Peretz , Scientific Director bei ImmuneCarta, einen Kurzlehrgang zu ... intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien im Rahmen der jährlich ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a global ... development of a novel system for quantitative immunohistochemistry ... the University of Rochester (NY, USA) and Konica-Minolta ... new system is able to accurately quantify the ... (Human epidermal growth factor receptor-2) in clinical samples. ...
Breaking Biology Technology:
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
(Date:2/7/2017)... WARSAW, Ind. , Feb. 7, 2017 ... global leader in musculoskeletal healthcare, will present at the ... Lotte New York Palace Hotel on Wednesday, February 15, ... A live webcast of the presentation can be accessed ... for replay following the conference via Zimmer Biomet,s Investor ...
Breaking Biology News(10 mins):